AZD9056

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Rheumatoid Arthritis

Phase 1

Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056

CompletedNCT00700986

AstraZenecaRheumatoid Arthritis

Start: 2008-06-30End: 2008-08-31Target: 12Updated: 2010-12-01

A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients

WithdrawnNCT00920608

AstraZenecaRheumatoid Arthritis

Start: 2009-05-31End: 2009-09-30Target: 12Updated: 2010-12-03

Phase 2

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

CompletedNCT00520572

AstraZenecaRheumatoid Arthritis

Start: 2007-08-31End: 2009-03-31Updated: 2013-02-04

Related Papers

Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine.

2012-10-01258 citations